Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Sarcoma
What adjuvant therapy would you recommend for a patient with a sarcomatoid carcinoma of the submandibular gland after R1 resection?
No lymph node dissection. cN0
Answer from: Radiation Oncologist at Academic Institution
Postop RT
Sign In
or
Register
to read more
17171
Related Questions
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
How would you approach adjuvant treatment in a patient with completely resected undifferentiated pleomorphic sarcoma of the chest wall that recurred after 2 years, initially treated with neoadjuvant radiation and resection?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
Is there a role for reirradiation for SCC oral tongue with high-risk features (i.e., PNI, close margins) following surgery?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
What alternatives do you recommend for oral dexamethasone solution for HN cancer?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
How are you integrating the findings from KEYNOTE-689 into daily practice?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?